The use of psilocybin, the hallucinogenic compound found in “magic mushrooms,” is rising in the United States alongside de‑criminalization efforts in several states and local jurisdictions, as well […]
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders. […]
In an effort to increase access to evidence-based interventions to help manage anxiety and depression, Mass General Brigham investigators have developed and tested a novel digital intervention called HabitWorks. HabitWorks […]
Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined […]
A new University of Missouri study suggests mental health policies can play a significant role in how Americans choose political candidates. Past scholarly research has found that most […]
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is […]
GLP-1 medications, which are used to treat diabetes and obesity, appear to be associated with reduced hospital care and sickness absence from work for psychiatric reasons, researchers reported […]
New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that excessive smartphone use is closely associated with disordered eating, including uncontrolled eating and emotional overeating, as […]
Experts are warning that far from being over diagnosed, people with ADHD are waiting too long for assessment, support and treatment. In a paper, published today in the British […]
Researchers report that patients diagnosed with cancer who subsequently develop a mental disorder are at an increased risk of all-cause death. The findings were published on Feb. 23, […]
After developing an AI tool that recommends antidepressants based on medical history, George Mason University researchers are now examining whether additional patient demographics, such as race and ethnicity, can improve the […]
Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of death, brain surgery or longer hospital stays, according […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
